Developer docs
API playgroundTry for free, no card

Search company profiles

Clarity Labs

Full company profile

uuid000ku4b

Namestring
Clarity Labs
Legal namestring
Clarity Laboratories, LLC
Websiteurl
claritylabs.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Clarity Labs is a CLIA-certified, CAP-accredited, high-complexity clinical diagnostic laboratory headquartered in Warren, New Jersey, operating since 2017. The company provides a broad menu of diagnostic testing services anchored by toxicology screening using its proprietary T.E.L.L.S. methodology, which leverages LC-MS (Liquid Chromatography-Mass Spectrometry) and tandem mass spectrometry to deliver lower cutoffs and fewer false positives than standard immunoassay methods. The test menu spans up to 120 analytes and extends into routine clinical chemistry, COVID-19 PCR and rapid testing, allergy diagnostics, molecular/NAAT testing, cytology (FNAC, LBC), pharmacogenetics and genetic testing, women's health (PAP, HPV, STI), therapeutic drug monitoring, and substance abuse program testing.

The company operates a B2B, sales-led model targeting healthcare providers, behavioral health facilities, addiction treatment and substance abuse programs, hospitals, surgical centers, and medical practices across the United States. Providers order tests through requisition forms or a secure web portal; specimens are processed at the Warren, NJ laboratory with additional specimen collection at a Butler, NJ service center, and results are returned electronically. The company holds state accreditations in New Jersey, New York, Pennsylvania, Maryland, and California, in addition to federal CLIA certification and CAP accreditation, and operates under HIPAA and GDPR-compliant data handling.

Revenue is generated primarily through insurance billing for laboratory testing services, with patients responsible for co-pays, coinsurance, and deductibles; a self-pay price list is also published. The company employs dedicated service representatives per account and offers customized specimen pickup and delivery schedules. Clarity Labs is privately held and controlled by its co-founders, with no disclosed external venture or private equity ownership on the primary US entity.

Short descriptiontext

Clarity Labs is a CLIA-certified, CAP-accredited New Jersey clinical laboratory operating since 2017, providing toxicology screening via proprietary LC-MS technology alongside routine clinical, COVID-19, allergy, molecular, genetic, and women's health testing to healthcare providers and addiction treatment facilities across the US.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWarren, United States
HQ citystring
Warren
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, toxicology screening, diagnostic testing, mass spectrometry testing, substance abuse testing
Industry2 codes
1Toxicology & Therapeutic Drug Monitoring Laboratories
CodeHLAFAMAFPrimaryYes
2Reference & Esoteric Testing Laboratories
CodeHLAFAMAJPrimaryNo
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Medical Laboratories621511
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Diagnostic Laboratory Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Laboratory Testing Services
TypeSubscription Recurring
Description

Clarity Labs performs diagnostic testing ordered by healthcare providers and reports results back to providers. They bill insurance providers during this process, and patients may receive bills for co-pays, coinsurance, or deductibles. Self-pay options are also available.

claritylabs.com
2Insurance Billing and Self-Pay
TypeTransaction Fee
Description

Laboratory testing services billed to insurance providers. Patients may receive Explanation of Benefits (EOB) from insurance. Self-pay price list is available for uninsured or out-of-pocket patients.

claritylabs.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
Pricing details1 tier
1Standard Laboratory Testing with Insurance Billing
ModelSubscriptionBilling cadenceMonthly
Notes

Clarity Labs bills insurance providers directly. Patients may be responsible for co-pays, coinsurance, or deductibles depending on their specific health plan benefit.

claritylabs.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Clarity Labs is a CLIA-certified and CAP-accredited high-complexity clinical diagnostic laboratory that performs qualitative and quantitative toxicology, routine clinical, molecular, allergy, cytology, genetic, women's health, and COVID-19 testing. The laboratory is built around its proprietary T.E.L.L.S. mass spectrometry-based toxicology screening methodology, which screens up to 120 analytes with lower cutoff levels and fewer false positives than standard immunoassay testing. Services are ordered by healthcare providers and substance abuse treatment facilities, with results reported back through electronic portals or paper requisitions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • PCR results delivered in less than 24 hours for facilities with 180+ bed operations
+2 more records
Product overview1 text field

Clarity Labs is a state-of-the-art medical testing laboratory providing a comprehensive suite of diagnostic testing services. The company operates a unified laboratory platform offering core services centered around toxicology testing (including the proprietary T.E.L.L.S. mass spectrometry-based screening), routine clinical testing, and COVID-19 testing. The product portfolio spans multiple specialized testing modules including allergy testing, molecular/NAAT testing, cytology testing, genetic/pharmacogenetics testing, women's health testing, therapeutic drug monitoring, and substance abuse program testing. Additional value-added services include Client and Provider web portals for result access and account management. All services are delivered through CLIA-certified and CAP-accredited laboratory operations in New Jersey.

Product and service3 records
1Toxicology Testing
CategoryToxicology Testing
Description

Qualitative presumptive screening and quantitative LC/MS definitive confirmation toxicology testing covering alcohol, amphetamines, anticonvulsants, antipsychotics, antidepressants, barbiturates, benzodiazepines, muscle relaxants, nicotine, illicit drugs, opiates, opioids, stimulants, and synthetic drugs. Available via urine, oral fluid (saliva), and hair (on request). Sold to healthcare providers, substance abuse programs, drug courts, and employers.

2Routine Clinical Testing
CategoryClinical Diagnostic Testing
Description

Comprehensive clinical diagnostic testing including routine blood tests, metabolic panels, lipid panels, cardiac biomarkers, and coagulation panels for screening, diagnosis, and evaluation of diseases and health conditions. Sold to healthcare providers and medical practices.

3COVID-19 Testing
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Leading specialty toxicology laboratory using LC-MS/MS for definitive drug testing. Closely comparable to Clarity Labs in target customers (addiction treatment, behavioral health, pain management) and in the technology platform (mass spec-based screening with extensive analyte menus).

TypeDirect peer
Description

Specialty clinical and forensic toxicology lab offering LC-MS/MS-based testing to healthcare providers, justice system, and employers. Directly comparable on test methodology, customer overlap in substance abuse treatment, and national service footprint.

TypeDirect peer
Description

Specialty toxicology and behavioral health laboratory providing medication monitoring and substance use disorder testing. Comparable to Clarity Labs in serving addiction treatment centers with clinical-grade toxicology panels and dedicated account support.

TypeDirect peer
Description

Specialty pain management and substance abuse toxicology laboratory offering LC-MS/MS confirmation testing. Directly comparable on test menu, customer base (pain clinics, addiction treatment), and turnaround time-driven service model.

TypeDirect peer
Description

Toxicology laboratory providing drug screening and confirmation services to employers, clinicians, and legal markets. Comparable to Clarity Labs on toxicology core offering and forensic/drug court segment, though more employer-weighted.

TypeBroad incumbent
Description

Largest US clinical laboratory offering routine and esoteric testing including toxicology. Comparable as a competitor for the same provider customers, but operates a far broader portfolio (genetics, anatomic pathology, routine chemistry) at national scale.

TypeBroad incumbent
Description

Major national clinical lab network providing routine diagnostics, toxicology, women's health, and molecular testing. Overlaps with Clarity Labs across most test categories but with national logistics, payer contracts, and a much broader footprint.

TypeBroad incumbent
Description

Global clinical lab operator with US presence including BioReference Laboratories. Competes with Clarity Labs in routine clinical and specialty testing, with the scale and IT infrastructure of a multi-state reference lab network.

TypeBroad incumbent
Description

International testing services group with a US clinical diagnostics footprint. Comparable in offering toxicology, molecular, and specialty testing, but at far broader geographic and menu scale.

TypeEmerging player
Description

Specialty diagnostics company focused on early cancer detection via next-generation sequencing. While a different clinical area, comparable as a specialized clinical lab leveraging advanced analytical technology to differentiate from generalist incumbents.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clarity Labs

Clinical Diagnostic Laboratory Servicesclaritylabs.com

Clarity Labs is a CLIA-certified, CAP-accredited New Jersey clinical laboratory operating since 2017, providing toxicology screening via proprietary LC-MS technology alongside routine clinical, COVID-19, allergy, molecular, genetic, and women's health testing to healthcare providers and addiction treatment facilities across the US.

What Clarity Labs does

Clarity Labs is a CLIA-certified, CAP-accredited, high-complexity clinical diagnostic laboratory headquartered in Warren, New Jersey, operating since 2017. The company provides a broad menu of diagnostic testing services anchored by toxicology screening using its proprietary T.E.L.L.S. methodology, which leverages LC-MS (Liquid Chromatography-Mass Spectrometry) and tandem mass spectrometry to deliver lower cutoffs and fewer false positives than standard immunoassay methods. The test menu spans up to 120 analytes and extends into routine clinical chemistry, COVID-19 PCR and rapid testing, allergy diagnostics, molecular/NAAT testing, cytology (FNAC, LBC), pharmacogenetics and genetic testing, women's health (PAP, HPV, STI), therapeutic drug monitoring, and substance abuse program testing.

The company operates a B2B, sales-led model targeting healthcare providers, behavioral health facilities, addiction treatment and substance abuse programs, hospitals, surgical centers, and medical practices across the United States. Providers order tests through requisition forms or a secure web portal; specimens are processed at the Warren, NJ laboratory with additional specimen collection at a Butler, NJ service center, and results are returned electronically. The company holds state accreditations in New Jersey, New York, Pennsylvania, Maryland, and California, in addition to federal CLIA certification and CAP accreditation, and operates under HIPAA and GDPR-compliant data handling.

Revenue is generated primarily through insurance billing for laboratory testing services, with patients responsible for co-pays, coinsurance, and deductibles; a self-pay price list is also published. The company employs dedicated service representatives per account and offers customized specimen pickup and delivery schedules. Clarity Labs is privately held and controlled by its co-founders, with no disclosed external venture or private equity ownership on the primary US entity.

Clarity Labs firmographics

Firmographics
Name
Clarity Labs
Legal name
Clarity Laboratories, LLC
Website
https://claritylabs.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
Clarity Labs is a CLIA-certified, CAP-accredited New Jersey clinical laboratory operating since 2017, providing toxicology screening via proprietary LC-MS technology alongside routine clinical, COVID-19, allergy, molecular, genetic, and women's health testing to healthcare providers and addiction treatment facilities across the US.
Ownership category
akta.pro rank

Clarity Labs industry classification

Industry
Product category
Clinical Diagnostic Laboratory Services
NAICS
Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)
akta.pro secondary industry
Reference & Esoteric Testing Laboratories (HLAFAMAJ)

Keywords

  • Clinical laboratory services
  • Toxicology screening
  • Diagnostic testing
  • Mass spectrometry testing
  • Substance abuse testing

Where Clarity Labs is headquartered

Location

Headquarters

HQ city
Warren
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Clarity Labs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Laboratory Testing Services: Clarity Labs performs diagnostic testing ordered by healthcare providers and reports results back to providers. They bill insurance providers during this process, and patients may receive bills for co-pays, coinsurance, or deductibles. Self-pay options are also available.
  2. Insurance Billing and Self-Pay: Laboratory testing services billed to insurance providers. Patients may receive Explanation of Benefits (EOB) from insurance. Self-pay price list is available for uninsured or out-of-pocket patients.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyStandard Laboratory Testing with Insurance Billing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Clarity Labs product offering

Product offering

Core offering

Clarity Labs is a CLIA-certified and CAP-accredited high-complexity clinical diagnostic laboratory that performs qualitative and quantitative toxicology, routine clinical, molecular, allergy, cytology, genetic, women's health, and COVID-19 testing. The laboratory is built around its proprietary T.E.L.L.S. mass spectrometry-based toxicology screening methodology, which screens up to 120 analytes with lower cutoff levels and fewer false positives than standard immunoassay testing. Services are ordered by healthcare providers and substance abuse treatment facilities, with results reported back through electronic portals or paper requisitions.

Product overview

Clarity Labs is a state-of-the-art medical testing laboratory providing a comprehensive suite of diagnostic testing services. The company operates a unified laboratory platform offering core services centered around toxicology testing (including the proprietary T.E.L.L.S. mass spectrometry-based screening), routine clinical testing, and COVID-19 testing. The product portfolio spans multiple specialized testing modules including allergy testing, molecular/NAAT testing, cytology testing, genetic/pharmacogenetics testing, women's health testing, therapeutic drug monitoring, and substance abuse program testing. Additional value-added services include Client and Provider web portals for result access and account management. All services are delivered through CLIA-certified and CAP-accredited laboratory operations in New Jersey.

Differentiator

Problem solved

Functional benefit

Products and services

  • Toxicology Testing Qualitative presumptive screening and quantitative LC/MS definitive confirmation toxicology testing covering alcohol, amphetamines, anticonvulsants, antipsychotics, antidepressants, barbiturates, benzodiazepines, muscle relaxants, nicotine, illicit drugs, opiates, opioids, stimulants, and synthetic drugs. Available via urine, oral fluid (saliva), and hair (on request). Sold to healthcare providers, substance abuse programs, drug courts, and employers.
  • Routine Clinical Testing Comprehensive clinical diagnostic testing including routine blood tests, metabolic panels, lipid panels, cardiac biomarkers, and coagulation panels for screening, diagnosis, and evaluation of diseases and health conditions. Sold to healthcare providers and medical practices.
  • COVID-19 Testing

Quantifiable outcome

  • PCR results delivered in less than 24 hours for facilities with 180+ bed operations
  • +2 more outcomes

Companies that use Clarity Labs

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Clarity Labs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Clarity Labs partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Clarity Labs competitors and assessment

Company assessment

Direct peers

  • Millennium Health: Leading specialty toxicology laboratory using LC-MS/MS for definitive drug testing. Closely comparable to Clarity Labs in target customers (addiction treatment, behavioral health, pain management) and in the technology platform (mass spec-based screening with extensive analyte menus).
  • Aegis Sciences Corporation: Specialty clinical and forensic toxicology lab offering LC-MS/MS-based testing to healthcare providers, justice system, and employers. Directly comparable on test methodology, customer overlap in substance abuse treatment, and national service footprint.
  • Cordant Health Solutions: Specialty toxicology and behavioral health laboratory providing medication monitoring and substance use disorder testing. Comparable to Clarity Labs in serving addiction treatment centers with clinical-grade toxicology panels and dedicated account support.
  • Precision Toxicology: Specialty pain management and substance abuse toxicology laboratory offering LC-MS/MS confirmation testing. Directly comparable on test menu, customer base (pain clinics, addiction treatment), and turnaround time-driven service model.
  • US Drug Testing Laboratories: Toxicology laboratory providing drug screening and confirmation services to employers, clinicians, and legal markets. Comparable to Clarity Labs on toxicology core offering and forensic/drug court segment, though more employer-weighted.

Broad incumbents

  • Quest Diagnostics: Largest US clinical laboratory offering routine and esoteric testing including toxicology. Comparable as a competitor for the same provider customers, but operates a far broader portfolio (genetics, anatomic pathology, routine chemistry) at national scale.
  • Laboratory Corporation of America (Labcorp): Major national clinical lab network providing routine diagnostics, toxicology, women's health, and molecular testing. Overlaps with Clarity Labs across most test categories but with national logistics, payer contracts, and a much broader footprint.
  • Sonic Healthcare USA: Global clinical lab operator with US presence including BioReference Laboratories. Competes with Clarity Labs in routine clinical and specialty testing, with the scale and IT infrastructure of a multi-state reference lab network.
  • Eurofins Clinical Diagnostics (US): International testing services group with a US clinical diagnostics footprint. Comparable in offering toxicology, molecular, and specialty testing, but at far broader geographic and menu scale.

Emerging players

  • GRAIL (subsidiary of Illumina): Specialty diagnostics company focused on early cancer detection via next-generation sequencing. While a different clinical area, comparable as a specialized clinical lab leveraging advanced analytical technology to differentiate from generalist incumbents.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Clarity Labs social profiles

Digital presence

Clarity Labs compliance and trust

Trust signal

Compliance4 records

Clarity Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clarity Labs leadership team

Management profile

Number of profiles

Profiles5 records

Clarity Labs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clarity Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clarity Labs

What does Clarity Labs do?

Clarity Labs is a CLIA-certified and CAP-accredited high-complexity clinical diagnostic laboratory that performs qualitative and quantitative toxicology, routine clinical, molecular, allergy, cytology, genetic, women's health, and COVID-19 testing. The laboratory is built around its proprietary T.E.L.L.S. mass spectrometry-based toxicology screening methodology, which screens up to 120 analytes with lower cutoff levels and fewer false positives than standard immunoassay testing. Services are ordered by healthcare providers and substance abuse treatment facilities, with results reported back through electronic portals or paper requisitions.

Is Clarity Labs a public or private company?

Clarity Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Clarity Labs founded?

Clarity Labs was founded in 2017. It employs 101 to 250 people.

Where is Clarity Labs based?

Clarity Labs is headquartered in Warren, United States, in the North America region.

How does Clarity Labs make money?

Two revenue lines are on record. Clinical Laboratory Testing Services are the primary driver. The others are insurance Billing and Self-Pay.

Who are Clarity Labs's main competitors?

Direct peers on record are Millennium Health, Aegis Sciences Corporation, Cordant Health Solutions, Precision Toxicology and US Drug Testing Laboratories. Broad incumbents are Quest Diagnostics, Laboratory Corporation of America (Labcorp), Sonic Healthcare USA and Eurofins Clinical Diagnostics (US). GRAIL (subsidiary of Illumina) is listed as an emerging player.

Does Clarity Labs have an API?

No public API is recorded for Clarity Labs.

What industry is Clarity Labs in?

Clarity Labs's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAF, Toxicology & Therapeutic Drug Monitoring Laboratories, with a secondary code of HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals